Senescence of the brain: Focus on cognitive kinases

Current Pharmaceutical Design

Volumn 16, Issue 6, 2010, Pages 660-671

  Govoni, S ^a   Amadio, M ^a   Battaini, F ^b   Pascale, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aging; CaM kinase; ELAV; Memory; Protein kinase A; Protein kinase C; Tyrosine kinase

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 METHYLCATECHOL; ANIRACETAM; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BRYOSTATIN 1; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CATALPOL; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOCOSAHEXAENOIC ACID; FORSKOLIN; GINKGO BILOBA EXTRACT; HU ANTIGEN; HUPERZINE A; INSULIN; ISOENZYME; LEVACECARNINE; MITOGEN ACTIVATED PROTEIN KINASE; NOBILETIN; OXIRACETAM; PENTOXIFYLLINE; PHOSPHATIDYLSERINE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 2; PROTEIN TYROSINE KINASE A; RESVERATROL; ROLIPRAM; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG; PROTEIN KINASE;

AGING; BEHAVIOR; COGNITION; ENZYME ACTIVATION; HIPPOCAMPUS; HUMAN; LONG TERM MEMORY; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; WORKING MEMORY; ANIMAL; BRAIN; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN; COGNITION; HUMANS; MEMORY; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 77950224240     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883732     Document Type: Review

References (167)

1. Billard JM. Ageing, hippocampal synaptic activity and magnesium. Magnes Res 2006; 19: 199-215.
2. Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987; 237: 143-149
3. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997; 278: 412-419
4. Mora F, Segovia G, del Arco A. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain Res Rev 2007; 55: 78-88.
5. Pascale A, Amadio M, Govoni S, Battaini F. The aging brain, a key target for the future: the protein kinase C involvement. Pharmacol Res 2007; 55: 560-569
6. Micheau J, Riedel G. Protein kinases: which one is the memory molecule? Cell Mol Life Sci 1999; 55: 534-548
7. DeFelipe J. Brain plasticity and mental processes: Cajal again. Nat Rev Neurosci 2006; 7: 811-817
8. Rosenzweig ES, Barnes CA. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 2003; 69: 143-179
9. Bliss TV, Lømo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973; 232: 331-356
10. Lynch G, Rex CS, Chen LY, Gall CM. The substrates of memory: defects, treatments, and enhancement. Eur J Pharmacol 2008; 585: 2-13.
11. Pang PT, Lu B. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res Rev 2004; 3: 407-430
12. Lynch G. Memory enhancement: the search for mechanism-based drugs. Nat Neurosci 2002; 5: 1035-1038
13. Battaini F, Mochly-Rosen D. Happy birthday protein kinase C: past, present and future of a superfamily. Pharmacol Res 2007; 55: 461-466
14. Newton AC. Protein kinase C. IUBMB Life 2008; 60: 765-768
15. Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Annu Rev Neurosci 1994; 17: 551-567
16. Newton AC. Lipid activation of protein kinases. J Lipid Res 2009; 50: S266-S71.
17. Battaini F. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res 2001; 44: 353-361
18. Noguès X, Pascale A, Micheau J, Battaini F. Protein Kinase C. In: Riedel G, Platt B, Eds. Cellular Mechanisms of Memory Formation. Landes Bioscience 2004; vol.4.4: pp. 383-410.
19. Van der Zee EA, Luiten PG, Disterhoft JF. Learning-induced alterations in hippocampal PKC-immunoreactivity: a review and hypothesis of its functional significance. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 531-572
20. Bowers BJ, Christensen SC, Pauley JR, Paylor R, Yuva L, Dunbar SE, et al. Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice. J Neurochem 1995; 64: 2737-2746
21. Sunayashiki-Kusuzaki K, Lester DS, Schreurs BG, Alkon DL. Associative learning potentiates protein kinase C activation in synaptosomes of the rabbit hippocampus. Proc Natl Acad Sci USA 1993; 90: 4286-4289
22. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 1999; 285: 1870-1874
23. Chung HJ, Steinberg JP, Huganir RL, Linden DJ. Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression. Science 2003; 300: 1751-1755
24. Sacktor TC. PKMzeta, LTP maintenance, and the dynamic molecular biology of memory storage. Prog Brain Res 2008; 169: 27-40.
25. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S. Modified hippocampal long-term potentiation in PKC γ-mutant mice. Cell 1993; 75: 1253-1262
26. Abeliovich A, Paylor R, Chen C, Kim JJ, Wehner JM, Tonegawa S. PKC γ mutant mice exhibit mild deficits in spatial and contextual learning. Cell 1993; 75: 1263-1271
27. Kano M, Hashimoto K, Chen C, Abeliovich A, Aiba A, Kurihara H, et al. Impaired synapse elimination during cerebellar development in PKC γ mutant mice. Cell 1995; 83: 1223-1231
28. Chen C, Kano M, Abeliovich A, Chen L, Bao S, Kim JJ, et al. Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC γ mutant mice. Cell 1995; 83: 1233-1242
29. Zhang GR, Wang X, Kong L, Lu X, Lee B, Liu M, et al. Genetic enhancement of visual learning by activation of protein kinase C pathways in small groups of rat cortical neurons. J Neurosci 2005; 25: 8468-8481
30. Neill JC, Sarkisian MR, Wang Y, Liu Z, Yu L, Tandon P, et al. Enhanced auditory reversal learning by genetic activation of protein kinase C in small groups of rat hippocampal neurons. Mol Brain Res 2001; 93: 127-136
31. Pascale A, Milano S, Corsico N, Lucchi L, Battaini F, Arrigoni E, et al. Protein kinase C activation and anti-amnesic effect of acetyl-L-carnitine: "in vitro" and "in vivo" studies. Eur J Pharmacol 1994; 265: 1-7.
32. Lucchi L, Pascale A, Battaini F, Govoni S, Trabucchi M. Cognition stimulating drugs modulate PKC activity in cerebral cortex and hippocampus of adult rats. Life Sci 1993; 53: 1821-1832
33. Smith AM, Wehner JM. Aniracetam improves contextual fear conditioning and increases hippocampal γ-PKC activation in DBA/2J mice. Hippocampus 2002; 12: 76-85.
34. Friedman E, Wang HY. Effect of age on brain cortical protein kinase C and its mediation of 5-hydroxytryptamine release. J Neurochem 1989; 52: 187-192
35. Battaini F, Del Vesco R, Govoni S, Trabucchi M. Regulation of phorbol ester binding and protein kinase C activity in aged rat brain. Neurobiol Aging 1990; 11: 563-566
36. Battaini F, Elkabes S, Bergamaschi S, Ladisa V, Lucchi L, De Graan PN, et al. Protein kinase C activity, translocation, and conventional isoforms in aging rat brain. Neurobiol Aging 1995; 16: 137-148
37. Pascale A, Fortino I, Govoni S, Trabucchi M, Wetsel WC, Battaini F. Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem 1996; 67: 2471-2477
38. Colombo PJ, Wetsel WC, Gallagher M. Spatial memory is related to hippocampal subcellular concentrations of calcium- dependent protein kinase C isoforms in young and aged rats. Proc Natl Acad Sci USA 1997; 94: 14195-14199
39. Colombo PJ, Gallagher M. Individual differences in spatial memory among aged rats are related to hippocampal PKC γ immunoreactivity. Hippocampus 2002; 12: 285-289
40. Rossi MA, Mash DC, deToledo-Morrell L. Spatial memory in aged rats is related to PKCγ-dependent G-protein coupling of the M1 receptor. Neurobiol Aging 2005; 26: 53-68.
41. Van der Zee EA, Palm IF, O'Connor M, Maizels ET, Hunzicker-Dunn M, Disterhoft JF. Aging-related alterations in the distribution of Ca2+-dependent PKC isoforms in rabbit hippocampus. Hippocampus 2004; 14: 849-860
42. Fordyce DE, Wehner JM. Effects of aging on spatial learning and hippocampal protein kinase C in mice. Neurobiol Aging 1993; 14: 309-317
43. Pascale A, Noguès X, Marighetto A, Micheau J, Battaini F, Govoni S, et al. Cytosolic hippocampal PKC and aging: correlation with discrimination performance. Neuroreport 1998; 9: 425-429
44. Mochly Rosen D, Gordon AS. Anchoring proteins for PKC: a means for isoenzyme selectivity. FASEB J 1998; 12: 35-42.
45. Kheifets V, Mochly-Rosen D. Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res 2007; 55: 467-476
46. Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez- Carrera M, Laguna JC. Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs. Biochem Pharmacol 2004; 68: 1411-1421
47. Battaini F, Pascale A, Paoletti R, Govoni S. The role of anchoring protein RACK1 in PKC activation in the ageing rat brain. Trends Neurosci 1997; 20: 410-415
48. Racchi M, Govoni S, Solerte SB, Galli CL, Corsini E. Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery. Brain Res Brain Res Rev 2001; 37: 287-293
49. Martini A, Battaini F, Govoni S, Volpe P. Inositol 1,4,5 trisphosphate receptor and ryanodine receptor in the aging brain of Wistar rats. Neurobiol Aging 1994; 15: 203-206
50. Pascale A, Govoni S, Battaini F. Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples. Mol Neurobiol 1998; 16: 49-56
51. Wang HY, Pisano MR, Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol Aging 1994; 15: 293-298
52. Battaini F, Pascale A, Lucchi L, Pasinetti GM, Govoni S. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp Neurol 1999; 159: 559-564
53. Zhang GR, Liu M, Cao H, Kong L, Wang X, O'Brien JA, et al. Improved spatial learning in aged rats by genetic activation of protein kinase C in small groups of hippocampal neurons. Hippocampus 2009; 19: 413-423
54. Battaini F, Pascale A. Protein kinase C signal transduction regulation in physiological and pathological aging. Ann NY Acad Sci 2005; 1057: 177-192
55. Liu J, He QJ, Zou W, Wang HX, Bao YM, Liu YX, et al. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res 2006; 1123: 68-79.
56. Bastianetto S, Dumont Y, Han Y, Quirion R. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? CNS Neurosci Ther 2009; 15:76-83.
57. Etcheberrigaray R, Tan M, Dewachter I, Kuiperi C, Van der Auwera I, Wera S, et al. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice, Proc Natl Acad Sci USA 2004; 101: 11141-11146
58. Choi DS, Wang D, Yu GQ, Zhu G, Kharazia VN, Paredes JP, et al. PKC epsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci USA 2006; 103: 8215-8220
59. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003; 6: 153-162
60. Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, Alkon D, et al. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 1998; 12: 17-34.
61. Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging 1998; 19: 191-199
62. Brennan AR, Yuan P, Dickstein DL, Rocher AB, Hof PR, Manji H, et al. Protein kinase C activity is associated with prefrontal cortical decline in aging. Neurobiol Aging 2009; 30: 782-789
63. Birnbaum SG, Yuan PX, Wang M, Vijayraghvan S, Bloom AK, Davis DJ, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004; 306: 882-884
64. Martiny-Baron G, Fabbro D. Classical PKC isoforms in cancer. Pharmacol Res 2007; 55: 477-486
65. Alkon DL, Sun MK, Nelson TJ. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol Sci 2007; 28: 51-60.
66. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 2005; 36: 2781-2790
67. Nguyen PV, Kandel ER. A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices. J Neurosci 1996; 16: 3189-3198
68. Wang H, Ferguson GD, Pineda VV, Cundiff PE, Storm DR. Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat Neurosci 2004; 7: 635-642
69. Wong ST, Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, et al. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 1999; 23: 787-798
70. Frey U, Huang YY, Kandel ER. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993; 260: 1661-1664
71. Bernabeu R, Cammarota M, Izquierdo I, Medina JH. Involvement of hippocampal AMPA glutamate receptor changes and the cAMP/protein kinase A/CREB-P signalling pathway in memory consolidation of an avoidance task in rats. Braz J Med Biol Res 1997; 30: 961-965
72. Huang YY, Kandel ER. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 1998; 21: 169-178
73. de Toledo-Morrell L, Morrell F, Fleming S, Cohen MM. Pentoxifylline reverses age-related deficits in spatial memory. Behav Neural Biol 1984; 42: 1-8.
74. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci USA 1998; 95: 15020-15025
75. Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 2000; 23: 198-204.
76. Zhang HT, O'Donnell JM. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology (Berl) 2000; 150: 311-316
77. Randt CT, Judge ME, Bonnet KA, Quartermain D. Brain cyclic AMP and memory in mice. Pharmacol Biochem Behav 1982; 17: 677-680
78. Baxter MG. Age-related memory impairment. Is the cure worse than the disease? Neuron 2003; 40: 669-670
79. Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS, Arnsten AF. Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 2003; 40: 835-845
80. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AF. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 1999; 46: 1266-1274
81. Taylor JR, Birnbaum S, Ubriani R, Arnsten AF. Activation of cAMP-dependent protein kinase A in prefrontal cortex impairs working memory performance. J Neurosci 1999; 19: RC23.
82. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998; 21: 127-148
83. Yin JC, Tully T. CREB and the formation of long-term memory. Curr Opin Neurobiol 1996; 6: 264-268
84. Bito H, Deisseroth K, Tsien RW. CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996; 87: 1203-1214
85. Lu YF, Kandel ER, Hawkins RD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 1999; 19: 10250-10261
86. Taubenfeld SM, Wiig KA, Bear MF, Alberini CM. A molecular correlate of memory and amnesia in the hippocampus. Nat Neurosci 1999; 2: 309-310
87. Barco A, Alarcon JM, Kandel ER. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002; 108: 689-703.
88. Murphy DD, Segal M. Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc Natl Acad Sci USA 1997; 94: 1482-1487
89. Brightwell JJ, Gallagher M, Colombo PJ. Hippocampal CREB1 but not CREB2 is decreased in aged rats with spatial memory impairments. Neurobiol Learn Mem 2004; 81: 19-26.
90. Mouravlev A, Dunning J, Young D, During MJ. Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats. Proc Natl Acad Sci USA 2006; 103: 4705-4710
91. Nagakura A, Niimura M, Takeo S. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats. Br J Pharmacol 2002; 135: 1783-1793
92. Carlezon WA, Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005; 28: 436-445
93. Malinow R, Malenka RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002; 25: 103-126
94. Malinow R, Schulman H, Tsien RW. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 1989; 245: 862-866
95. Silva AJ, Stevens CF, Tonegawa S, Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992; 257: 201-206
96. Stevens CF, Tonegawa S, Wang Y. The role of calcium-calmodulin kinase II in three forms of synaptic plasticity. Curr Biol 1994; 4:687-693
97. Thomas KL, Laroche S, Errington ML, Bliss TV, Hunt SP. Spatial and temporal changes in signal transduction pathways during LTP. Neuron 1994; 13: 737-745
98. Ouyang Y, Rosenstein A, Kreiman G, Schuman EM, Kennedy MB. Tetanic stimulation leads to increased accumulation of Ca(2+)/calmodulin-dependent protein kinase II via dendritic protein synthesis in hippocampal neurons. J Neurosci 1999; 19: 7823-7833
99. Silva AJ, Paylor R, Wehner JM, Tonegawa S. Impaired spatial learning in α-calcium-calmodulin kinase II mutant mice. Science 1992; 257: 206-211
100. Ahmed T, Frey JU. Plasticity-specific phosphorylation of CaMKII, MAP-kinases and CREB during late-LTP in rat hippocampal slices in vitro. Neuropharmacology 2005; 49: 477-492
101. Skibinska-Kijek A, Radwanska A, Kossut M. Alpha calcium/calmodulin dependent protein kinase II in learning-dependent plasticity of mouse somatosensory cortex. Neuroscience 2008; 151: 750-757
102. Zhang GR, Cheng XR, Zhou WX, Zhang YX. Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Neuroscience 2009; 159: 308-315
103. McKee AC, Kosik KS, Kennedy MB, Kowall NW. Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinase. J Neuropathol Exp Neurol 1990; 49: 49-63.
104. Murray KD, Gall CM, Jones EG, Isackson PJ. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 1994; 60: 37-48.
105. Wang Q, Wang J. Injection of bradykinin or cyclosporine A to hippocampus induces Alzheimer-like phosphorylation of tau and abnormal behavior in rats. Chin Med J (Engl) 2002; 115: 884-887
106. Wayman GA, Lee YS, Tokumitsu H, Silva A, Soderling TR. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron 2008; 59: 914-931
107. Fukushima H, Maeda R, Suzuki R, Suzuki A, Nomoto M, Toyoda H, et al. Upregulation of calcium/calmodulin-dependent protein kinase IV improves memory formation and rescues memory loss with aging. J Neurosci 2008; 28: 9910-9919
108. Ho N, Liauw JA, Blaeser F, Wei F, Hanissian S, Muglia LM, et al. Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice. J Neurosci 2000; 20: 6459-6472
109. Kang H, Sun LD, Atkins CM, Soderling TR, Wilson MA, Tonegawa S. An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory. Cell 2001; 106: 771-783
110. Wei F, Qiu CS, Liauw J, Robinson DA, Ho N, Chatila T, et al. Calcium calmodulin-dependent protein kinase IV is required for fear memory. Nat Neurosci 2002; 5: 573-579
111. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429: 883-891
112. Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS One 2008; 3: e3329.
113. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 1998; 800: 125-135
114. Townsend M, Mehta T, Selkoe DJ. Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 2007; 282: 33305-33312
115. Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001; 177: 125-134
116. Amadio M, Govoni S, Alkon DL, Pascale A. Emerging targets for the pharmacology of learning and memory. Pharmacol Res 2004; 50: 111-122
117. Puglielli L. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit? Neurobiol Aging 2008; 29: 795-811.
118. Carro E, Torres-Aleman I. The role of insulin and insulin-like growth factor 1 in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 2004; 490: 127-133
119. Chung YH, Shin CM, Joo KM, Kim MJ, Cha CI. Region specific alterations in insulin-like growth factor receptor type I in the cerebral cortex and hippocampus of aged rats. Brain Res 2002; 946: 307-313
120. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2008; doi:10.1016/j.neurobiolaging.2008.04.002
121. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults. J Alzheimers Dis 2008; 13:323-331
122. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, et al. Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 2008; 70:440-448
123. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736.
124. Lu B. Acute and long-term synaptic modulation by neurotrophins. Prog Brain Res 2004; 146: 137-150
125. Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) 2006; 110: 175-191
126. Dechant G, BardeYA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131-1136
127. Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkAto-p75NTR molecular switch activates amyloid β-peptide generation during aging. Biochem J 2005, 391: 59-67.
128. Kelly A, Maguire C, Lynch MA. Deficits in nerve growth factor release and tyrosine receptor kinase phosphorylation are associated with age-related impairment in long-term potentiation in the dentate gyrus. Neuroscience 2000; 95: 359-365
129. Saragovi H. Progression of age-associated cognitive impairment correlates with quantitative and qualitative loss of TrkA receptor protein in nucleus basalis and cortex. J Neurochem 2005; 95: 1472-1480
130. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706-709
131. Klesse LJ, Parada LF. Trks: signal transduction and intracellular pathways. Microsc Res Tech 1999; 45: 210-216
132. Kelly-Spratt KS, Klesse LJ, Parada LF. BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signaling. J Neurosci Res 2002; 69: 151-159
133. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10: 381-391
134. Hawkins PT, Welch H, McGregor A, Eguinoa A, Gobert S, Krugmann S, et al. Signalling via phosphoinositide 3OH kinases. Biochem Soc Trans 1997; 25: 1147-1151
135. Maguire C, Casey M, Kelly A, Mullany PM, Lynch MA. Activation of tyrosine receptor kinase plays a role in expression of long-term potentiation in the rat dentate gyrus. Hippocampus 1999; 9: 519-526
136. Gooney M, Messaoudi E, Maher FO, Bramham CR, Lynch MA. BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes in cell signaling events. Neurobiol Aging 2004; 25: 1323-1331
137. Laurino L, Wang XX, de la Houssaye BA, Sosa L, Dupraz S, Cáceres A, et al. PI3K activation by IGF-1 is essential for the regulation of membrane expansion at the nerve growth cone. J Cell Sci 2005; 118: 3653-3662 (Pubitemid 41309412)
138. Ramsey MM, Adams MM, Ariwodola OJ, Sonntag WE, Weiner JL. Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. J Neurophysiol 2005; 94: 247-254
139. Martín-Peña A, Acebes A, Rodríguez JR, Sorribes A, de Polavieja GG, Fernández-Fúnez P, et al. Age-independent synaptogenesis by phosphoinositide 3 kinase. J Neurosci 2006; 26: 10199-10208
140. Maher FO, Martin DS, Lynch MA. Increased IL-1β in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase. Neurobiol Aging 2004; 25: 795-806.
141. Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005; 102: 10858-10863
142. Webster NJ, Park K, Pirrung MC. Signaling effects of demethylasterriquinone B1, a selective insulin receptor modulator. Chem Biochem 2003; 4: 379-385
143. Feng Y, Bhatt AJ, Fratkin JD, Rhodes PG. Neuroprotective effects of sodium orthovanadate after hypoxic-ischemic brain injury in neonatal rats. Brain Res Bull 2008; 76: 102-108
144. Sometani A, Nomoto H, Nitta A, Furukawa Y, Furukawa S. 4-Methylcatechol stimulates phosphorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons. J Neurosci Res 2002; 70: 335-339
145. Wolkow CA, Kimura KD, Lee MS, Ruvkun G. Regulation of C. Elegans life-span by insulin-like signalling in the nervous system. Science 2000; 290: 147-150
146. Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology 2003; 4: 1-8.
147. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008; 105: 3438-3442
148. Erickson CA, Barnes CA. The neurobiology of memory changes in normal aging. Exp Gerontol 2003; 38: 61-69
149. Gallagher M, Rapp PR. The use of animal models to study the effects of aging on cognition. Annu Rev Psychol 1997; 48: 339-370
150. Frey U, Morris RG. Synaptic tagging and long-term potentiation. Nature 1997; 385: 533-536
151. Reymann KG, Frey JU. The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 2007; 52: 24-40.
152. Gao FB. Messenger RNAs in dendrites: localization, stability, and implications for neuronal function. Bioessays 1998; 20: 70-78
153. Tiruchinapalli DM, Ehlers MD, Keene JD. Activity-dependent expression of RNA binding protein HuD and its association with mRNAs in neurons. RNA Biol 2008; 5: 157-168
154. Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci 2008; 65: 3168-3181
155. Pascale A, Gusev PA, Amadio M, Dottorini T, Govoni S, Alkon DL, et al. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci USA 2004; 101: 1217-1222
156. Pascale A, Amadio M, Quattrone A. Defining a neuron: neuronal ELAV proteins. Cell Mol Life Sci 2008; 65: 128-140
157. Quattrone A, Pascale A, Noguès X, Zhao W, Gusev P, Pacini A, et al. Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins. Proc Natl Acad Sci USA 2001; 98: 11668-11673
158. Pascale A, Amadio M, Scapagnini G, Lanni C, Racchi M, Provenzani A, et al. Neuronal ELAV proteins enhance mRNA stability by a PKCα-dependent pathway. Proc Natl Acad Sci USA 2005; 102: 12065-12070
159. Amadio M, Battaini F, Pascale A. The different facets of protein kinases C: old and new players in neuronal signal transduction pathways. Pharmacol Res 2006; 54: 317-325
160. Fülöp T, Jr, Seres I. Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention. Drugs Aging 1994; 5: 366-390
161. Amadio M, Pascale A, Wang J, Ho L, Quattrone A, Gandy S, et al. nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-β reverberating on AβPP processing. J Alzheimers Dis 2009; 16: 409-419
162. Xu Y, Cui C, Pang C, Christen Y, Luo Y. Restoration of impaired phosphorylation of cyclic AMP response element-binding protein (CREB) by EGb 761 and its constituents in Aβ-expressing neuroblastoma cells. Eur J Neurosci 2007; 26: 2931-2939
163. Nagase H, Yamakuni T, Matsuzaki K, Maruyama Y, Kasahara J, Hinohara Y, et al. Mechanism of neurotrophic action of nobiletin in PC12D cells. Biochemistry 2005; 44: 13683-13691
164. Stramiello M, Wagner JJ. D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs. Neuropharmacology 2008; 55: 871-877
165. Lanni C, Stanga S, Racchi M, Govoni S. The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr Pharm Des 2009; in press.
166. Sun MK, Alkon DL. Effects of 4-methylcatechol on spatial memory and depression. Neuroreport 2008; 19: 355-359
167. Rispoli V, Marra R, Costa N, Rotiroti D, Tirassa P, Scipione L, et al. Choline pivaloyl ester enhances brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis. Behav Brain Res 2008; 190: 22-32.